Concepedia

Andy Hsu

AH

Statistics

Publications

6

Citations

545

H-Index

6

Active since

2010

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash University

Andy Hsu is an author at Peter MacCallum Cancer Centre specializing in medicine, cancer immunotherapy, and immunology.

Publications per year

2010–2016

6

Publications

6

AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy

Megan V. Astle, Katherine M. Hannan, Puiyee Ng et al. · Oncogene · 2011 · 288 citations · Full text

Medicine, Cell Biology, Oncology +17

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

Andy Hsu, Hang Quach, Tsin Yee Tai et al. · Blood · 2010 · 156 citations · Full text

Life Sciences, Immunology, Pharmacology +15

The Drug Vehicle and Solvent N-Methylpyrrolidone Is an Immunomodulator and Antimyeloma Compound

Jake Shortt, Andy Hsu, Benjamin Martin et al. · Cell Reports · 2014 · 39 citations · Full text

Medicine, Oncology, Pharmacology +13

Functional outcomes in Hirschsprung disease: A single institution's 12-year experience

Hemanshoo Thakkar, Christopher Bassett, Andy Hsu et al. · Journal of Pediatric Surgery · 2016 · 38 citations

Medicine, Pediatrics, Surgery +8

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant

Simon J. Harrison, Andy Hsu, Paul J. Neeson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 12 citations

Medicine, Immunology, Oncology +16

1–5 of 6